Open AccessClinical efficacy of Vortioxetine and escitalopram in the treatment of depression
Author(s) -
Shichuan Shao,
Baomin Sun,
Huiqing Sun
Publication year - 2022
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.38.5.5230
Subject(s) - medicine , escitalopram , hamd , vortioxetine , depression (economics) , hamilton depression scale , clinical efficacy , incidence (geometry) , adverse effect , treatment and control groups , major depressive disorder , psychiatry , significant difference , antidepressant , cognition , physics , macroeconomics , optics , economics , hippocampus
This study was aimed to investigate the efficacy and safety of vortioxetine hydrobromide in the treatment of major depressive disorder (MDD).